Endonovo Therapeutics Stock Price on January 8, 2025
ENDV Stock | USD 0.0003 0.0001 25.00% |
If you're considering investing in Endonovo Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Endonovo Therapeutics stands at 0.0003, as last reported on the 24th of January, with the highest price reaching 0.0003 and the lowest price hitting 0.0003 during the day. Endonovo Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0141, which denotes the company had a -0.0141 % return per unit of standard deviation over the last 3 months. Endonovo Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Endonovo Therapeutics' Standard Deviation of 18.01, coefficient of variation of (25,080), and Mean Deviation of 10.97 to check the risk estimate we provide.
Endonovo Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Endonovo |
Sharpe Ratio = -0.0141
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ENDV |
Estimated Market Risk
19.01 actual daily | 96 96% of assets are less volatile |
Expected Return
-0.27 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Endonovo Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Endonovo Therapeutics by adding Endonovo Therapeutics to a well-diversified portfolio.
Related Headline
Purple Biotech Headline on 8th of January 2025
Purple Biotech Expands ATM Offering by 1.33 Million - MSN by news.google.com
Purple Biotech Expands ATM Offering by 1.33 Million MSN
Endonovo Therapeutics Valuation on January 8, 2025
It is possible to determine the worth of Endonovo Therapeutics on a given historical date. On January 8, 2025 Endonovo was worth 4.0E-4 at the beginning of the trading date compared to the closed value of 4.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Endonovo Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Endonovo Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Endonovo Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Endonovo Therapeutics' related companies.
Open | High | Low | Close | Volume | |
0.0005 | 0.0005 | 0.0005 | 0.0005 | 175,000 | |
01/08/2025 | 0.0004 | 0.0004 | 0.0004 | 0.0004 | 26,745,000 |
0.0004 | 0.0004 | 0.0003 | 0.0004 | 49,339,300 |
Backtest Endonovo Therapeutics | | | Endonovo Therapeutics History | | | Endonovo Therapeutics Valuation | Previous | Next |
Endonovo Therapeutics Trading Date Momentum on January 8, 2025
On January 10 2025 Endonovo Therapeutics was traded for 0.0004 at the closing time. The top price for the day was 0.0004 and the lowest listed price was 0.0003 . The trading volume for the day was 49.3 M. The trading history from January 10, 2025 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Endonovo Therapeutics Fundamentals Correlations and Trends
By evaluating Endonovo Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Endonovo Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Endonovo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Endonovo Therapeutics Pink Sheet history
Endonovo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Endonovo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Endonovo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Endonovo Therapeutics stock prices may prove useful in developing a viable investing in Endonovo Therapeutics
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California. Endonovo Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Endonovo Therapeutics Pink Sheet Technical Analysis
Endonovo Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Endonovo Therapeutics Period Price Range
Low | January 24, 2025
| High |
0.00 | 0.00 |
Endonovo Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Endonovo Therapeutics January 24, 2025 Market Strength
Market strength indicators help investors to evaluate how Endonovo Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Endonovo Therapeutics shares will generate the highest return on investment. By undertsting and applying Endonovo Therapeutics pink sheet market strength indicators, traders can identify Endonovo Therapeutics entry and exit signals to maximize returns
Endonovo Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Endonovo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Endonovo Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Endonovo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0061 | |||
Jensen Alpha | 0.0694 | |||
Total Risk Alpha | (0.89) | |||
Treynor Ratio | 0.0206 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Endonovo Pink Sheet Analysis
When running Endonovo Therapeutics' price analysis, check to measure Endonovo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endonovo Therapeutics is operating at the current time. Most of Endonovo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Endonovo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endonovo Therapeutics' price. Additionally, you may evaluate how the addition of Endonovo Therapeutics to your portfolios can decrease your overall portfolio volatility.